Form 8-K X4 Pharmaceuticals, Inc For: Aug 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
X4 Pharmaceuticals directors resign, board appointments made
August 25, 2025 8:16 AM EDTX4 Pharmaceuticals Inc. (NASDAQ: XFOR) announced that two directors resigned from its board effective immediately on August 22, 2025.
David McGirr and R. Keith Woods stepped down from the board of directors and all committees. The company stated the resignations were not due to any disagreement... More



